Is ROSN or MRK a better dividend investment in 2026?

ROSN currently yields 9523.81% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ROSN offers higher current income.

What is the dividend yield difference between ROSN and MRK?

ROSN has a forward dividend yield of 9523.81% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 9521.05 percentage points.

Home › Compare › ROSN vs MRK

ROSN vs MRK: Dividend Comparison 2026

ROSN yields 9523.81% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ROSN wins by $34096885384495640.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ROSN

● Live price

9523.81%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34096885384495640.00M

Annual income

$33,406,863,634,510,780,000,000.00

Full ROSN calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ROSN vs MRK

📍 ROSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ROSN	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ROSN + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ROSN pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ROSN

Annual income on $10K today (after 15% tax)

$809,523.81/yr

After 10yr DRIP, annual income (after tax)

$28,395,834,089,334,163,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ROSN beats the other by $28,395,834,089,334,163,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ROSN + MRK for your $10,000?

ROSN: 50%MRK: 50%

100% MRK50/50100% ROSN

Portfolio after 10yr

$17048442692247820.00M

Annual income

$16,703,431,817,255,390,000,000.00/yr

Blended yield

97.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ROSN

No analyst data

Altman Z

-300.0

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ROSN buys

MRK buys

No recent congressional trades found for ROSN or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricROSNMRK

Forward yield	9523.81% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$34096885384495640.00M ✓	$56.8K
Annual income after 10y	$33,406,863,634,510,780,000,000.00 ✓	$9,798.13
Total dividends collected	$34050931359582140.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ROSN vs MRK ($10,000, DRIP)

Year	ROSN Portfolio	ROSN Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$963,081	$952,380.95	$11,206	$366.19	+$951.9K → ROSN
2	$86,751,988	$85,721,491.09	$12,650	$502.35	+$86.74M → ROSN
3	$7,309,257,562	$7,216,432,935.10	$14,407	$694.19	+$7309.24M → ROSN
4	$576,061,994,112	$568,241,088,520.80	$16,585	$967.82	+$576061.98M → ROSN
5	$42,471,142,252,811	$41,854,755,919,110.81	$19,342	$1,363.89	+$42471142.23M → ROSN
6	$2,929,381,022,509,453	$2,883,936,900,298,945.50	$22,913	$1,947.19	+$2929381022.49M → ROSN
7	$189,036,367,688,831,520	$185,901,929,994,746,400.00	$27,662	$2,823.89	+$189036367688.80M → ROSN
8	$11,413,921,216,762,330,000	$11,211,652,303,335,279,000.00	$34,159	$4,173.35	+$11413921216762.29M → ROSN
9	$644,880,140,172,767,400,000	$632,667,244,470,831,700,000.00	$43,337	$6,308.80	+$644880140172767.38M → ROSN
10	$34,096,885,384,495,640,000,000	$33,406,863,634,510,780,000,000.00	$56,776	$9,798.13	+$34096885384495640.00M → ROSN

ROSN vs MRK: Complete Analysis 2026

ROSN — Stock

Maverick Technology Solutions engages in the development and production of extraction presses and accessories for extracting organic solventless concentrates. Its products include consumer targeted ROSINBOMB Rocket presses and commercially targeted ROSINBOMB M-50 presses, and related accessories. The company sells its products through distributors and retailers, as well as directly at rosinbomb.com. Maverick Technology Solutions is based in Phoenix, Arizona.

Full ROSN Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ROSN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ROSN vs SCHD ROSN vs JEPI ROSN vs O ROSN vs KO ROSN vs MAIN ROSN vs JNJ ROSN vs ABBV ROSN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.